Literature DB >> 18678237

Phytochemistry and in vitro pharmacological activities of South African Vitex (Verbenaceae) species.

E Nyiligira1, A M Viljoen, F R Van Heerden, R L Van Zyl, S F Van Vuuren, P A Steenkamp.   

Abstract

AIM OF THE STUDY: The in vitro phytochemical and pharmacological investigation of the non-volatile extracts of five South African Vitex species (Verbenaceae); V. obovata ssp. obovata, V. obovata ssp. wilmsii, V. pooara, V. rehmannii and V. zeyheri were investigated in order to validate their traditional use to treat a wide range of ailments such as malaria, wounds, skin diseases and body pains.
MATERIAL AND METHODS: The antimicrobial activity was assessed using the minimum inhibitory concentration assay. Through bioactivity-guided fractionation, the fraction responsible for the antimicrobial activity was determined. The toxicity profile, anti-oxidant and anti-inflammatory activity was evaluated using the tetrazolium cellular viability, 2,2-diphenyl-1-picrylhydrazyl and 5-lipoxygenase assays respectively. The antimalarial activity of the extracts and isolated compound from V. rehmannii was also investigated on the chloroquine-resistant Gambian FCR-3 strain of Plasmodium falciparum using the tritiated hypoxanthine incorporation assay.
RESULTS: Mostly good antimicrobial inhibition was evident against Gram-positive bacteria (0.02-8.00 mg/ml) and lower activity against the Gram-negative bacteria and the yeast (0.50-8.00 mg/ml). The fraction responsible for antimicrobial activity of V. rehmannii was purified to give a labdane diterpene as an inseparable epimeric mixture of 12S,16S/R-dihydroxy-ent-labda-7,13-dien-15,16-olide. Cirsimaritin was also isolated and identified from V. rehmannii. All the species, apart from V. zeyheri, exhibited scavenging activity (IC50: 22.14+/-1.74 to 33.06+/-1.68 microg/ml) in the anti-oxidant assay. None of the species displayed any anti-inflammatory activity at 100 microg/ml. All the extracts and the labdane diterpene exhibited good antimalarial activity, with the labdane diterpene being the most active (IC50: 2.39+/-0.64 microg/ml). The test extracts were shown to be highly toxic, displaying safety index values ranging from 0.53 to 2.59.
CONCLUSION: Of all the pharmacological investigations, the antimalarial and antimicrobial activity exhibited greatest activity and may provide a scientific basis for the ethnomedical use of Vitex species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18678237     DOI: 10.1016/j.jep.2008.07.004

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  5 in total

1.  Preliminary evaluation of the wound healing effect of Vitex doniana sweet (Verbenaceae) in mice.

Authors:  K Amegbor; K Metowogo; K Eklu-Gadegbeku; A Agbonon; K A Aklikokou; G Napo-Koura; M Gbeassor
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-07-01

2.  Melanogenesis-inducing effect of cirsimaritin through increases in microphthalmia-associated transcription factor and tyrosinase expression.

Authors:  Hyo Jung Kim; Il Soon Kim; Yin Dong; Ik-Soo Lee; Jin Sook Kim; Jong-Sang Kim; Je-Tae Woo; Byung-Yoon Cha
Journal:  Int J Mol Sci       Date:  2015-04-20       Impact factor: 5.923

3.  Antiplasmodial potential and quantification of aloin and aloe-emodin in Aloe vera collected from different climatic regions of India.

Authors:  Sandeep Kumar; Manila Yadav; Amita Yadav; Pooja Rohilla; Jaya Parkash Yadav
Journal:  BMC Complement Altern Med       Date:  2017-07-17       Impact factor: 3.659

4.  Biosynthesis of bioactive diterpenoids in the medicinal plant Vitex agnus-castus.

Authors:  Allison M Heskes; Tamil C M Sundram; Berin A Boughton; Niels B Jensen; Nikolaj L Hansen; Christoph Crocoll; Federico Cozzi; Simon Rasmussen; Britta Hamberger; Björn Hamberger; Dan Staerk; Birger L Møller; Irini Pateraki
Journal:  Plant J       Date:  2018-02-14       Impact factor: 6.417

Review 5.  The genus Vitex: A review.

Authors:  Anita Rani; Anupam Sharma
Journal:  Pharmacogn Rev       Date:  2013-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.